• Navigation überspringen
  • Zur Navigation
  • Zum Seitenende
Organisationsmenü öffnen Organisationsmenü schließen
Friedrich-Alexander-Universität Division of Pharmaceutical Biology
  • FAUZur zentralen FAU Website
  1. Friedrich-Alexander-Universität
  2. Naturwissenschaftliche Fakultät
  3. Department Biologie
Suche öffnen
    1. Friedrich-Alexander-Universität
    2. Naturwissenschaftliche Fakultät
    3. Department Biologie
    Friedrich-Alexander-Universität Division of Pharmaceutical Biology
    Menu Menu schließen
    • Research
      • Biogenic avenues
      • Extracellular vesicles
      • Cardenolides in cancer therapy
      • Publications
        • Jennifer Munkert
      Portal Research
    • Teaching
      • Wahlpflichtfach Pharmazie
      • Excursions
      • Links
      Portal Teaching
    • Staff
      • Job offers
      Portal Staff
    • Location
      • Travel directions
      Portal Location
    1. Startseite
    2. Research
    3. Extracellular vesicles

    Extracellular vesicles

    Bereichsnavigation: Research
    • Sustainability
    • Biogenic avenues
    • Extracellular vesicles
    • Cardenolides in cancer therapy
    • Publications
    • Junior Research Group: Bacterial Interface Dynamics

    Extracellular vesicles

    Extracellular vesicles and bacterial outer membrane vesicles

    Our focus is on the characterisation of extracellular vesicles (EVs) as natural conveyers of cellular information. EVs are nanoparticles of 50-200 nm in size that are produced naturally by virtually all eukaryotic and prokaryotic cells. EVs consists of a lipid double layer, carry signal molecules, such as proteins or nucleic acids (e.g. microRNA), and are very efficient cell-cell communicators that migrate from one cell type to another, interact with the target cell by means of their surface and membrane proteins and thus transfer signal molecules in a highly specific manner.

    We are interested to understand the role of EVs during infection but we also want to use these biogenic carriers to transfer molecules of choice to target tissue. We aim at incorporating these drug-loaded EVs in a pharmaceutical formulation and evaluate its efficiency in complex in vitro and in vivo models. Moreover, we isolate and characterise bacterial EVs and study how these interact with other bacteria, bacterial biofilms or human cells and which physiological role they have. New therapeutic approaches to combat bacterial infections can be derived from these studies.

    Friedrich-Alexander-Universität
    Erlangen-Nürnberg

    Schlossplatz 4
    91054 Erlangen
    • Impressum
    • Datenschutz
    • Barrierefreiheit
    • Facebook
    • RSS Feed
    • Twitter
    • Xing
    Nach oben